发明授权
- 专利标题: Sustained release intraocular implants and methods for preventing retinal dysfunction
-
申请号: US10837143申请日: 2004-04-30
-
公开(公告)号: US08425929B2公开(公告)日: 2013-04-23
- 发明人: Glenn T. Huang , James Burke , Patrick M. Hughes , Kai-Ming Zhang , Ton Lin , Larry A. Wheeler , Rosy Sheng Donn
- 申请人: Glenn T. Huang , James Burke , Patrick M. Hughes , Kai-Ming Zhang , Ton Lin , Larry A. Wheeler , Rosy Sheng Donn
- 申请人地址: US CA Irvine
- 专利权人: Allergan, Inc.
- 当前专利权人: Allergan, Inc.
- 当前专利权人地址: US CA Irvine
- 代理商 Louis V. Wollenberger; Joel B. German; Debra D. Condino
- 主分类号: A61F2/02
- IPC分类号: A61F2/02
摘要:
Biocompatible intraocular implants include an alpha-2 adrenergic receptor agonist and a polymer associated with the alpha-2 adrenergic receptor agonist to facilitate release of the alpha-2 adrenergic receptor agonist into an eye for an extended period of time. The alpha-2 adrenergic receptor agonist may be associated with a biodegradable polymer matrix, such as a matrix of a two biodegradable polymers. The implants may be placed in an eye to prevent the occurrence of one or more ocular conditions, or to reduce one or more symptoms of an ocular condition, such as an ocular neurosensory disorder and the like.